RECRUITING

Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants who have had a stroke at least 6 months before enrolment and experience persistent balance and gait deficits. Participants will be randomized into three groups: (1) robotic balance training with active brain stimulation, (2) robotic balance training with sham brain stimulation, and (3) standard-of-care rehabilitation. The study will involve 15 training sessions over 5 weeks, with assessments conducted at baseline, post-training, and two months post-training to evaluate balance recovery and retention. The primary focus is understanding how this intervention affects brain and muscle activity during balance tasks and how these changes translate into functional improvements in clinical outcome measures of balance function. Additionally, participant feedback on brain stimulation and exercise engagement will be collected to inform future studies. The findings may guide the development of personalized training protocols and contribute to broader rehabilitation strategies.

Official Title

Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke

Quick Facts

Study Start:2025-06-01
Study Completion:2029-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07113041

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Aged between 18-75 years
  2. 2. Diagnosed with a cortical/subcortical ischemic stroke at least 6 months before the screening, as confirmed by the neurological exam or an MRI.
  3. 3. Have complaints of impaired balance and poor postural control determined by a BBS score of ≤50.
  4. 4. Ability to stand upright with or without support for at least 20 seconds
  5. 5. Ability to walk with or without a walking aid for at least ten meters
  6. 6. Not planning to change medication in the next four months
  7. 7. Minimum Cognitive Ability to understand the verbal instructions and comply with the study procedures, as determined by the University of California, San Diego, Brief Assessment of Capacity to Consent Instrument (UBACC).
  1. 1. Currently undergoing any regular physical therapy program or research studies focusing on balance functions.
  2. 2. Having a brainstem stroke.
  3. 3. Contraindication for MRI scan (presence of metal implants, claustrophobia)
  4. 4. Affected by the peripheral nerve injury, neuromuscular conditions, or orthopedic issues of lower limbs before stroke, or have any persistent pain or difficulty maintaining blood pressure while upright.
  5. 5. Have a scalp or skin condition (e.g., psoriasis or eczema) \* on the scalp near the stimulation site
  6. 6. Having severe visual impairment (e.g., spatial neglect) or hearing problems that may affect study compliance
  7. 7. Any other neurological injury or psychiatric conditions (e.g., severe anxiety or schizophrenia etc.)
  8. 8. Contraindications to MRI, including the presence of non-titanium metallic implants, claustrophobia, etc.
  9. 9. Not be pregnant or thinking of becoming pregnant
  10. 10. Diagnosed with alcohol or substance abuse in the last 3 years
  11. 11. Contraindications to TMS, including the presence of metallic implants in the head and a history of seizures or medication-resistant epilepsy or ongoing use of anti-seizure/seizure threshold-lowering medications.

Contacts and Locations

Study Contact

Vikram Shenoy Handiru, PhD
CONTACT
9733243578
vshenoy@kesslerfoundation.org
Kathleen Goworek, B.S.
CONTACT
kgoworek@kesslerfoundation.org

Principal Investigator

Vikram Shenoy Handiru,, PhD
PRINCIPAL_INVESTIGATOR
Kessler Foundation
Guang Yue, PhD
STUDY_DIRECTOR
Kessler Foundation
Gail Forrest, PhD
STUDY_DIRECTOR
Kessler Foundation

Study Locations (Sites)

Kessler Foundation
West Orange, New Jersey, 07052
United States

Collaborators and Investigators

Sponsor: Kessler Foundation

  • Vikram Shenoy Handiru,, PhD, PRINCIPAL_INVESTIGATOR, Kessler Foundation
  • Guang Yue, PhD, STUDY_DIRECTOR, Kessler Foundation
  • Gail Forrest, PhD, STUDY_DIRECTOR, Kessler Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-01
Study Completion Date2029-08-31

Study Record Updates

Study Start Date2025-06-01
Study Completion Date2029-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Stroke
  • Stroke (CVA) or Transient Ischemic Attack
  • Stroke Ischemic
  • Stroke Gait Rehabilitation
  • Balance Deficits